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Abstract
Liver transplantation is the definitive treatment of liver failure but donor organ shortage limits
its availability. Stem cells are highly expandable and have the potential to differentiate into
any specialist cell. Use of patient-derived induced Pluripotent Stem Cells (hiPSCs) has the
additional advantage for organ regeneration therapies by removing the need for immuno-
suppression. We compared hepatocyte differentiation of human embryonic stem cells
(hESCs) and hiPSCs in a mouse decellularised liver scaffold (3D) with standard in vitro pro-
tocol (2D). Mouse livers were decellularised preserving micro-architecture, blood vessel net-
work and extracellular matrix. hESCs and hiPSCs were primed towards the definitive
endoderm. Cells were then seeded either in 3D or 2D cultures and the hepatocyte differenti-
ation was continued. Both hESCs and hiPSCs differentiated more efficiently in 3D than in
2D, with higher and earlier expression of mature hepatocyte marker albumin, lipid and glyco-
gen synthesis associated with a decrease in expression of fetal hepatocyte marker alpha-
fetoprotein. Thus we conclude that stem cell hepatocyte differentiation in 3D culture pro-
motes faster cell maturation. This finding suggests that optimised 3D protocols could allow
generation of mature liver cells not achieved so far in standard 2D conditions and lead to
improvement in cell models of liver disease and regenerative medicine applications.
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Introduction
Liver disease is the third most common cause of premature death in the UK. In 2012, in
England and Wales, 600,000 people had some form of liver disease [1] whilst in 2013, it
affected 30 million Americans [2]. Liver disease includes alcohol-related liver disease, viral
hepatitis, non-alcoholic fatty liver disease, autoimmune and inherited liver disorders. In 2013,
29 million Europeans had a form of chronic liver condition [3]. Globally, liver cirrhosis was
responsible for over one million deaths which correspond to approximately 2% of all deaths
worldwide [4], in 2010; and 10,948 deaths were due to liver cirrhosis, in 2012, in the UK [1].
Liver transplantation is the primary treatment for severe liver failure; however, it is currently
limited by organ shortage [5].
Over the last few decades, a number of alternative approaches to liver transplantation have
been developed including bioartificial liver support systems (BAL) and primary hepatocytes
transplantation. The use of BAL (extracorporeal bioreactors in which liver cells are cultured in
a network of hollow fibres for blood plasma perfusion) is limited by the lack of a reliable, safe,
metabolically active and easily expandable human cell source. Furthermore, BAL membranes
do not provide an appropriate molecule exchange mechanism [6]. In a recent study, Shi et al
used human fibroblasts directly reprogrammed into human hepatocytes in a BAL support sys-
tem and showed promising results in metabolic detoxification and ammonia elimination.
However, the cells used did not acquire many of the mature hepatocyte functions and the
exchange between blood, plasma and cells remained limited [7]. On the other hand, hepatocyte
transplantation has shown promise as a short-term treatment for specific metabolic liver disor-
ders; however, as yet, this approach has not had a significant impact upon treatment of acute
liver failure and chronic liver disease. The application of this treatment modality is limited by
the lack of a sufficient source of viable primary hepatocytes and poor cell engraftment in situ
[6, 8, 9].
A possible answer to the lack of an easily expandable human cell source is the use of
patient-derived induced Pluripotent Stem cells (hiPSCs) [10]. These cells have the potential to
differentiate into any cell type [11] and the added advantage of removing the need for immu-
nosuppression. hiPSCs differentiation protocols utilised so far [12–14] have the limitation to
allow cells to achieve only fetal-like hepatocyte phenotype [13, 15], whereby the cells lack any
ability to perform many mature hepatocyte functions. Full maturation to an adult phenotype is
however necessary to allow transplantation of these cells in an adult setting.
Normal cell physiology and function strongly depend on cell-cell and cell-extracellular
matrix (ECM) interactions in the 3D environment. Several studies have demonstrated that pri-
mary human hepatocytes (PHH) grown in 3D systems [16–18] maintain the state of differenti-
ation better as evidenced by improved function, enhanced cell polarization and canalicular
formation. Gieseck et al showed that hiPSC-derived hepatocytes grown in the RAFT (3D cell
clumps in 3D Real Architecture For 3D Tissues) system had a more mature phenotype than
those grown in 2D with more prominent intercellular junctions [19, 20]. Besides the mechani-
cal stimuli related to the 3D environment, naturally derived ECM has also the advantage of
delivering tissue-specific signalling which have a role in the regulation of liver cell function
[21], migration and proliferation [22]. In particular key components of ECM, such as laminin,
may assist the differentiation of stem cells into hepatocytes [23]. As a consequence, fewer cyto-
kines and growth factors may be required in the media for hepatocyte differentiation from
human hepatic stem cells cultured in scaffolds after decellularisation than on cells grown on
collagen type I -coated dishes [24]. This influence is so powerful that in fetal and adult hepato-
cytes, it promotes expression of adult genes in adult hepatocyte ECM or the expression of fetal
genes in fetal hepatocyte ECM, respectively [25].
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In this study, we tested mouse decellularised liver scaffolds as a platform for stem cells to
hepatocyte differentiation in order to combine the advantages of a 3D environment with the
benefits provided by the ECM components.
A mouse decellularised liver scaffold, which we have previously shown to preserve extracel-
lular matrix components and fine hepatic microarchitecture, was used to seed previously
endoderm stage primed hiPSCs and hESCs [26, 27] (3D cultures). Mouse decellularised liver
scaffolds are easily available and can be repopulated with a relatively small amount of cells
compared to human decellularised liver scaffolds. The differentiation stage of the stem cells
cultured in 3D was compared to that of cells that underwent a conventional differentiation
protocol on matrigel-coated dishes (2D cultures) by analysis of hepatocyte markers
expression.
Materials and methods
Animals and ethics statement
This study was carried out in accordance with the recommendations in the UK Animal (Scien-
tific Procedures) Act 1986. The UK Home Office approved the study protocol (licence number
70/2716). The work was approved by the London-Hampstead NRES ethics committee REC
reference 13/LO/0171.
All animals were housed in accordance with the UK Home Office guidelines: in dedicated
rooms with controlled temperature, humidity, noise levels and lighting mimicking a natural
sleep/wake cycle, and within individually ventilated cages with appropriate bedding and with
ad lib access to food and water. All cages had nesting material and environmental enrichment.
All animals were checked at least once a day by a competent person, any animals that raised
concerns were checked by the Named Animal Care and Welfare Officer and if necessary the
Named Veterinary Surgeon. All animals were euthanized using a rising concentration of CO2
with minimal animal suffering. No live animals were used for this project and organs were har-
vested ex vivo from mice. In order to minimise the number of animals, more than one organ
was harvested from each animal according to the needs of other researchers in the institute. A
total of 35 livers have been harvested ex vivo from 35 mice.
Harvest of organs
Organs were obtained from CD-1 mice, aged 3 to 4 months. Livers were harvested as described
in rats [26]. Briefly, after the sacrifice of the mouse using increasing CO2 inhalation, a midline
incision was performed to expose the abdominal cavity. The portal vein (PV) was cannulated
with a 24G cannula (BD, UK), secured with a 3/0 silk suture (Ethicon, UK). The inferior vena
cava (IVC) was ligated using a 3/0 silk suture placed proximally to the right renal vein while
the superior one was sectioned and left opened to allow the reagents to flow out. The dia-
phragm, once detached from the insertions, was used as holding point. The whole procedure
was carried out to avoid damages to the Glisson’s capsule.
Decellularisation protocol
Mouse livers were decellularised in a similar manner as rat livers using the Detergent Enzy-
matic Treatment (DET) method with a few modifications [26]. The PV was connected to a
peristaltic pump (Masterflex, UK) and perfused with demineralised water (dH2O) (18.2 mO/
cm) for 36 hours at 4˚C followed by 4% sodium deoxycholate (SDC) (Sigma-Aldrich, UK) for
4h at room temperature (RT). Finally, after a 30 minutes wash with PBS, the liver was perfused
with 2,000 kU solution of deoxyribonuclease-I (DNase-I, Sigma-Aldrich, UK) in 1 M sodium
Decellularised liver scaffold improves stem cells differentiation into hepatocyte-like cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0189586 December 20, 2017 3 / 23
chloride for 3h at RT. All the reagents were perfused at a rate of 3 ml/min. The obtained
mouse liver scaffolds were sterilised by gamma-irradiation before seeding cells.
Cells and culture conditions
H1, a well-established embryonic stem cell line was used as hESCs line (WiCell Stem cell bank,
WA01) [28]. The hiPSCs line was a generous gift from Prof. L. Vallier (corrected A1ATD-
hiPSCs [29]). Stem cells were cultured in mTeSR1 medium (Stem cell technologies, UK) on
matrigel growth factor reduced (Corning, UK) coated dishes. Media was changed daily and
cells were split every 3–5 days with a mixture of collagenase IV and dispase II (Thermofisher,
UK) [13]. All cells were tested monthly for the lack of mycoplasma contamination using the
MycoAlert Mycoplasma Detection Kit (Lonza, UK).
Differentiation protocol
hESCs and hiPSCs were differentiated into hepatocyte-like cells as described with a few mod-
ifications [12]. Stem cells were cultured until 80–90% confluency. They were split 1/6 on
matrigel-coated dishes and let rest for 1–2 days with daily change of mTeSR1. They were
then incubated with priming media Roswell Park Memorial Institute (RPMI) (Thermofisher,
UK) and 1x B27 (ThermoFisher, UK) with 100 ng/ml activin A (Peprotech,UK) and 50 ng/
ml Wnt3a (R&D systems, UK) for 3 days followed by 2-days incubation in 100 ng/mL activin
A alone. At this point, Definitive Endoderm-like Cells (DECs) were harvested with enzyme-
free Cell Dissociation Buffer (ThermoFisher, UK), avoiding remaining stem cells colonies
and seeded in specification medium SR/DMSO (KO/DMEM containing 20% KO Serum
Replacement, 1 mM L-glutamine, 1% NEAA, 0.1 mM β-mercaptoethanol, and 1% dimethyl
sulfoxide) with rock inhibitor Y-27632 (Sigma-Aldrich, UK) for 1 overnight. For 2D cul-
tures, DECs were seeded on matrigel-coated dishes: 6x104 per well of a u-Slide 8 wells (Ibidi,
Uk) or 5.4x105 per 35 mm dish. For 3D cultures, the decellularised mouse liver was dissected
into individual lobes and 2.5x106 DECs in 200 μl of media were injected into 3 points of one
decellularised lobe with a 29G microfine syringe (BD, UK), this was repeated 3 times draw-
ing up the cells leaking out of the lobe after each injection. The seeded lobe was kept in a 24
wells plate with 500 μl of media and its size varied from 0.25–0.5 cm3. DECs, differentiated
in parallel, were fixed and analysed afterwards by immunofluorescence staining for sox17, an
endoderm marker. The media was then changed every 2 days for a further 4 days. During the
final maturation step of 9 days, cells were fed every 2 days up to day 13 of differentiation with
L-15 medium supplemented with 8.3% FBS, 8.3% tryptose phosphate broth, 10 μM hydro-
cortisone 21-hemisuccinate, 1 μM insulin (Sigma-Aldrich, UK), 2 mM glutamine, 10 ng/mL
hepatocyte growth factor HGF (Peprotech, UK) and 20 ng/mL oncostatin M (Peprotech,
UK). All media after the endoderm stage were supplemented with the antimicrobial Primo-
cin (Invivogen, FR).
DNA quantification
DNA was isolated using a tissue DNA isolation kit (PureLink Genomic DNA MiniKit, Invi-
trogen, UK) following the manufacturer’s instructions. The samples were digested overnight
using Proteinase K. DNA samples were purified using alcohol washes and measured
spectrophotometrically (Nanodrop, Thermo Scientific, US). Optical densities at 260 nm and
280 nm were used to estimate the purity and yield of nucleic acids. 4 biological replica were
analysed.
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Scanning electron microscopy (SEM)
SEM-images of the cross-section, top and bottom surfaces of the decellularised scaffold were
taken to examine surface-topography of the material. Samples were fixed in 3% glutaraldehyde
(Sigma-Aldrich,UK; G5882) in 0.1m phosphate buffer and kept at 4˚C. Scaffolds were first
washed in 0.1m phosphate buffer (pH 7.4), then post-fixed with 1% Osmium tetraoxide
(OsO4) / 1.5% Potassium Ferrocyanide K4(Fe(CN)6) in 0.1m phosphate buffer, followed by
dH2O wash. Specimens were then dehydrated in a graded ethanol-water series to 100% ethanol
and critical point-dried using CO2. Next, samples were mounted onto aluminium stubs using
sticky carbon taps, so that the surfaces of interest were presented to the beam. Samples were
coated with a 2nm-thin layer of Au/Pd using a Gatan ion-beam coater and viewed using a Jeol
7401 FEG-SEM.
Samples preparation for immunostaining
To characterize the decellularisation of the mouse liver, fresh and DET liver were fixed in 4%
paraformaldehyde PFA (Sigma-Aldrich, UK), dehydrated in graded alcohol, paraffin embed-
ded and sectioned at 5μm.
After the differentiation protocol, for the 3D cultures, the liver lobes were embedded in
OCT compound (VWR, UK) on a bath of isopentane (Sigma-Aldrich, UK) cooled in liquid
nitrogen and sectioned at 6 μm on a cryostat. For the 2D cultures, cells were grown either
on matrigel-coated u-Slide 8 well (Ibidi, Uk) or matrigel-coated 35 mm dishes and then
fixed.
Immunostainings: Haematoxylin & eosin, collagen, elastin, and
glycosaminoglycans
Paraffin-embedded tissue sections were stained with haematoxylin and eosin (H&E; Leica,
Germany), Picrosirius Red (Merck Sigma Aldrich., Germany) for collagen, Elastin Van Gieson
(Millers Elastin, TCS Biosciences, UK) for elastin, and Alcian Blue (AB; BDH Chemicals Ltd,
Cellpath Ltd) stains for glycosaminoglycans (GAG). Appropriate positive controls were used
to ensure histological stains were performed correctly (small intestine for PR and AB, lung for
EVG). For all histological samples, three biological and technical replicates were assessed using
standard H&E prior to any special stains to ensure homogeneity. All images shown are repre-
sentative samples.
For H&E staining, cryosections of 3D cultures and 2D cultured cells on matrigel-coated
dishes were fixed in 4% PFA in PBS 15 min, rinse with PBS followed by tap water. They were
incubated with Hematoxylin QS (Vector Laboratories, UK) 1–2 min, rinsed with tap water 5
min, and incubated with Eosin Y solution (Sigma-Aldrich, UK) for 30 sec. They were dehy-
drated with 95% then 100% EtOH, dipped in Histoclear (ThermoFisher scientific, UK) and
mounted in a non-aqueous mounting medium.
Lipid storage staining (Oil Red O)
Cryosections and cells on matrigel-coated dishes were fixed in 4% PFA in PBS 15 min. Sam-
ples were then incubated with filtered Oil Red O (ORO) working solution for 15 min (3 parts
ORO stock solution (300 mg of ORO powder (Sigma-Aldrich, UK) into 100 ml of 99–100%
isopropanol) with 2 parts demineralized water (dH2O)). Afterwards, they were rinsed with
tap water, counterstained with Hematoxylin QS for 1 min and finally rinsed with tap water
till the solution ran clear. Samples were kept dry or mounted in non-aqueous mounting
medium.
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Glycogen storage staining (Periodic Acid Schiff)
Periodic Acid Schiff (PAS) was performed according to the manufacturer instructions (395B-
1KT, Sigma-Aldrich, UK). Cryosections and cells on matrigel-coated dishes were fixed in 4%
PFA in PBS 15–20 min. They were rinsed 3 times with tap water and incubated with Periodic
Acid solution for 5 min. They were then rinsed with dH2O, 3 times for 5 min followed by an
incubation with Schiff Reagent for 15 min, and finally rinsed 3 times with tap water for 5 min.
Samples were counterstained with Hematoxylin QS for 1 min, rinsed with tap water and
mounted in permanent mounting medium.
Immunofluorescence stainings
Cryosections and cells on matrigel-coated dishes were fixed in 4% paraformaldehyde (PFA)
for 15 min alone, methanol for 8–10 min alone or 4% PFA followed by methanol depending
on the primary antibody. They were quenched with 10 mM NH4Cl for 10 min, permeabilised
in 0.25% Triton X100 for 15 min, and blocked in appropriate blocking buffer for 1h. After
overnight incubation with the primary antibody, samples were incubated with the appropriate
AlexaFluor-conjugated secondary antibodies (S1 Table), counterstained with DAPI, treated 1
min with 0.1% Sudan Black B in 70% ethanol and mounted using Vectashield or Prolong
Gold.
Microscopy
All immunofluorescence images were acquired using Leica TCS SPE3 and SP5 confocal micro-
scopes using 20x and 40x objectives. Leica Application Suite Advanced Fluorescence software
was used for basic analysis of the confocal images. The images of ORO, PAS or H&E staining
and bright field images of cells morphology were captured with an EVOS XL Core microscope
using a 20x objective for the 2D cultures and Zeiss Axioplan2 microscope using a 20x and 40x
objectives for the 3D cultures. Fiji software (Image J 1.50d) was used for counting the number
of positively stained cells [30]. For nuclear staining, the threshold was adjusted so that the
most of positive nuclei were visible for all images, then the plugin Analyze Particles was used
with or without a Watershed filter. For cytoplasmic staining, the positive cells were counted
manually with the help of the Cell Counter plugin.
Statistics
For DNA quantification, a two-tailed Mann-Whitney test was performed as the normality of
the population could not be assumed.
For analysis of the hepatocytes markers, a minimum of 3 separate differentiation experi-
ments were analysed. The proportion of positively stained cells was analysed for each marker
for each image (n) comparing the 4 groups: hESCs 2D or 3D and hiPSCs 2D or 3D (S2 Table).
The populations were represented by a boxplot of the percentages of positive cells for each
marker for each group. The bottom and top of the box are the first (Q1 or 25th percentile) and
third quartiles (Q3 or 75th percentile), and the band inside the box is the median. The ends of
the whiskers represent the minimum and maximum. Mild outliers () are individual points
with a value greater than Q3 + 1.5 x InterQuartile Range (IQR = Q3-Q1) or less than Q1–1.5 x
IQR. Extreme outliers (▲) have a value greater than Q3 + 3 x IQR or less than Q1–3 x IQR.
All data points were included in the statistical analysis including outliers.
A two-tailed non-parametric Kruskal-Wallis test was performed because the populations
could not be assumed to be Gaussian, as demonstrated by the Shapiro-Wilk normality test.
This was followed by the Dunn Bonferroni posthoc test which enabled pairwise comparisons
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of the 4 groups. To aid the interpretation of the results, median, minimum and maximum
were reported as well as mean rank for each group (S2 Table). The Mann-Whitney and Krus-
kal-Wallis tests compare medians if it can be assumed that the groups have similar distribu-
tions and compare mean ranks if this assumption cannot be made. The equality of variances
among groups was tested with a non-parametric Levene test, and it was found that the groups
did not have similar distribution for Alphafetoprotein (AFP), Cytokeratin 18 (CK-18), Cyto-
keratin (CK-19), and ORO measurements.
For all tests, a p value lower than 0.05 was considered significant. Statistical difference level
on the graph was indicated by  for p<0.05 and  for p<0.01 according to the results of the
statistical test. All tests were performed using the statistical software SPSS v24 (IBM, US).
Results
Characterisation of mouse liver scaffolds
Decellularisation of the mouse livers was performed as described previously by detergent-
enzymatic treatment (DET) [26]. By the end of the procedure, translucent livers were obtained
(Fig 1a) with no detectable cells on H&E staining (Fig 1b) and minimal remaining DNA within
the decellularised scaffold (Figs 1c and 2a). Scanning Electron Microscopy (SEM) showed the
preservation of the three-dimensional network of connective tissue fibres (Fig 1d). The persis-
tence of major ECM components such as collagen, elastin and glycosaminoglycans (GAGs) in
the scaffold was confirmed by immunohistochemistry (Fig 2b–2d).
Differentiation of hiPSCs and hESCs into hepatocyte-like cells within 3D
or 2D cultures
hESCs and hiPSCs lines that had successfully been used to generate hepatocyte-like cells in 2D
were utilised in this work [29, 31]. A previously established protocol was used for hepatocyte
differentiation of stem cells [12, 32, 33]. hiPSCs and hESCs were first primed towards the
definitive endoderm on matrigel-coated petri dishes. Definitive Endoderm-like cells (DECs)
were then harvested using a non-enzyme cell dissociation buffer. The efficiency of differentia-
tion towards endoderm cells was evaluated by immunofluorescence staining of sox17 positive
cells. On 13 differentiation batches analysed, the highest percentage of sox17 positive cells per
differentiation batch was 89.23±35% for hESC-derived endoderm and 91.42±5.77% for hiPSC-
derived endoderm. On average 45.42±24.64% (hESCs) and 56.95±21.28% (hiPSCs) of cells
were sox17 positive and were able to further differentiate into hepatocyte-like cells. As a low
percentage of sox17 cells at endoderm stage predicts poor hepatocyte differentiation, the dif-
ferentiation batches that were less than 15% sox17 positive were excluded from this study [13].
The DECs were then either seeded in 2D cultures or injected into several points of one lobe
isolated from a mouse decellularised liver (3D cultures), which was then kept by itself in a petri
dish in static conditions. The differentiation was then continued in parallel in 3D and 2D
using hepatic specification stage media followed by the hepatic maturation stage-specific
media.
For all experiments, the 2D and 3D cultures were compared on day 13 of differentiation
(Fig 3, part of the illustrations were published in Maghsoudlou et al, figures 1 and 6 [26]).
Repopulation of decellularised liver scaffolds by hiPSC- and hESC-
derived cells
We first studied whether the cells were capable of engrafting within the scaffold. DAPI staining
and H&E staining at a higher magnification of cryosections of the individually repopulated
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Fig 1. Mouse liver decellularisation. (a) Macroscopic appearance of a mouse liver scaffold during the decellularisation process.
Following the perfusion with demineralized water (dH2O), the fresh red liver becomes blanched. After perfusion with sodium
deoxycholate (SDC) followed by DNAseI solution, the liver becomes transparent. (b) H&E staining of the liver sections shows no cells
in the scaffold after DET decellularisation. (c) DNA quantification shows a significant (*) reduction of DNA amount in the DET liver
(median = 0.093 μg/mg) compared to fresh tissue (median = 1.068 μg/mg) (nFresh = 4, nDET = 4; α = 0.05; p = 0.029; two-tailed Mann-
Whitney test). (d) Scanning Electron Microscopy demonstrating the preservation of the three-dimensional network of connective tissue
fibres.
https://doi.org/10.1371/journal.pone.0189586.g001
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decellularised liver lobes demonstrated that hESC- or hiPSC-derived cells successfully repopu-
lated the scaffolds and appear to be positioned along the scaffold fibres (Fig 4a and 4b). Scan-
ning Electron Microscopy (SEM) of the 3D cultures revealed that cells were present within the
hepatic spaces (Fig 4c). Ki67, a marker of proliferation shows substantial areas of cell prolifera-
tion (Fig 4d); while, cleaved caspase 3 (cc3), a marker of apoptosis, shows a minimal amount
of apoptotic cells among the 3D cultured cells (Fig 5). 2D cultured cells start to acquire a polyg-
onal shape on day 13 of differentiation (Fig 6).
Earlier expression of mature hepatocytes markers in 3D cultured hiPSC-
and hESC-derived hepatocytes
Expression of characteristic hepatocyte markers was analysed on day 13 of differentiation in
hiPSC- and hESC-derived cells. Positive cells for each marker were scored and reported as a
percentage of the total number of cells identified by their positive DAPI staining of their nuclei
for each image. Median expression of albumin (ALB) was 44.2% of the hESCs and 87.7% of the
hiPSCs cultured in 3D, significantly different to only 4.15% for hESCs and 4.17% for hiPSCs
cultured in 2D (p = 3.33E-16; α = 0.05; two-tailed Kruskal-Wallis test with Dunn-Bonferroni
posthoc test). In particular, posthoc tests show that when comparing the expression of ALB
Fig 2. Characterisation of the mouse liver scaffold decellularised by DET method. (a) DAPI (grey) staining
of sections of a DET mouse liver scaffold shows efficient decellularisation of the fibres with no nucleus present. (b)
Picosirius red (PR) staining shows an abundance of collagen fibres in the scaffold. (c) Alcian Blue (AB) staining
demonstrates presence of glycosaminoglycans (GAG). (d) Elastin van Gieson staining (EVG) confirms presence
of elastin.
https://doi.org/10.1371/journal.pone.0189586.g002
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between 3D and 2D culture conditions (p2DhESCsvs3DhESCs = 2.44E-5, p2DhiPSCsvs3DhiPSCs =
1.55E-11), the difference was found to be very significant (Fig 7a, 7b and 7e, S2 Table). Inter-
estingly, there was no significant difference between hESC- and hiPSC-derived hepatocytes
when cultured in 2D (p2DhESCsvs2DhiPSCs = 1) but there was a significant difference between
hESC- and hiPSC-derived hepatocytes when cultured in 3D (p3DhESCsvs3DhiPSCs = 0.011).
On the contrary, median expression of alpha-fetoprotein (AFP) was 0% (hESCs) and 5.11%
(hiPSCs) in 3D and was significantly different to 34.89% (hESCs) and 32.37% (hiPSCs) in 2D
(p = 5.318 E-13; α = 0.05; two-tailed Kruskal-Wallis test with Dunn-Bonferroni posthoc test).
According to the posthoc tests, the difference was very significant between hESC-derived
hepatocytes cultured either in 2D or in 3D (p2DhESCsvs3DhESCs = 1.704E-10) as well as between
hESC- and hiPSC-derived hepatocytes grown in 3D (p3DhESCsvs3DhiPSCs = 5.06E-6) (Fig 7c, 7d
and 7f. S2 Table). Moreover, there was no significant difference between hESC- and hiPSC-
derived hepatocytes when cultured in 2D (p2DhESCsvs2DhiPSCs = 1), nor was there any significant
difference between hiPSCs grown in 2D or in 3D (p2DhiPSCsvs3DhiPSCs = 0.311). As the variances
of the 4 groups for AFP are unequal (non-parametric Levene test, α = 0.05, p = 0.016), the
Kruskal-Wallis test compares the mean ranks of the groups, rather than the medians. The
mean ranks for hiPSCs grown in 2D or in 3D are quite similar; however, it is clear from their
median expressions that they are biologically different.
Fig 3. Differentiation of hiPSCs and hESCs in 2D or 3D cultures. hiPSCs and hESCs were differentiated first towards the definitive endoderm.
Definitive Endoderm-like cells (DECs) were then harvested and either seeded on matrigel-coated petri dishes (2D cultures) or injected into multiple
locations in individual decellularised liver lobes (3D cultures) on day 6. The differentiation protocol was continued in parallel in both systems with the
hepatic specification stage from d7-d11 followed by the hepatic maturation stage from d11. The differentiation was continued up to day 13 when the
samples were analysed. Part of the illustrations were published in Maghsoudlou et al [26].
https://doi.org/10.1371/journal.pone.0189586.g003
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Fig 4. Repopulation of a mouse decellularised liver scaffold with hiPSC- and hESC-derived
hepatocytes on day 13 of differentiation. (a-b) Nuclear staining by DAPI shows that cells have attached
along the fibres of the scaffold (a) and that they repopulated the hepatic spaces as shown by H&E staining (b).
(c) Scanning Electron Microscopy demonstrates engraftment of cells within the hepatic spaces of the scaffold.
(d) Ki67 (proliferation marker) staining of sections of mouse liver scaffold repopulated with hESC- or hiPSC-
derived hepatocytes. Nuclei counterstained with DAPI.
https://doi.org/10.1371/journal.pone.0189586.g004
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Our results, therefore show that a higher percentage of 3D cultured stem cell-derived hepa-
tocytes expressed ALB, a mature cytoplasmic hepatocyte marker, whereas expression of AFP, a
fetal cytoplasmic hepatocyte marker, was much lower in 3D than in 2D cultured cells.
HNF4α, a nuclear protein detected from early stages in hepatocyte differentiation and
essential for specification of hepatocyte progenitors from pluripotent stem cells [34], was
highly expressed in 2D cultured cells up to day 13, and was also present in cells grown on scaf-
folds (Fig 8).
Fig 5. Minimal apoptosis amongst hiPSC- and hESC-derived hepatocytes cultured in 3D on day 13 of
differentiation. Cleaved caspase 3 (red) staining demonstrates only occasional apoptotic cells. Nuclei
stained with DAPI.
https://doi.org/10.1371/journal.pone.0189586.g005
Fig 6. Morphology of hiPSC- or hESC-derived cells in 2D on day 13 of differentiation. Phase contrast
microscopy shows cells starting to acquire a polygonal shape.
https://doi.org/10.1371/journal.pone.0189586.g006
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Fig 7. ALB and AFP expression by hiPSC- or hESC-derived hepatocytes on day 13 of differentiation. (a-b)
Immunostaining of ALB shows more widespread expression in 3D (b) than in 2D (a). Nuclei stained with DAPI. (c-d)
Immunostaining shows fewer cells expressing AFP in 3D (d) than in 2D (c). Nuclei stained with DAPI. (e-f) Boxplots
of percentages of positive cells for ALB (e) and AFP (f) for each group. The bottom and top of the box are the first and
third quartiles, and the band inside the box is the median. The ends of the whiskers represent the minimum and
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We subsequently looked at intermediate filament proteins cytokeratin 18 (CK-18) and cyto-
keratin 19 (CK-19), which are both expressed at the hepatoblast stage of hepatocyte differentia-
tion. In mature cells, CK-18 marks hepatocytes whereas CK-19 expression is specific to
cholangiocytes [35, 36]. Median expression of CK-18 was 36.17% for the hESC-derived hepa-
tocytes and 45.25% for the hiPSCs in 3D cultured cells and was significantly different to hESC-
derived hepatocytes (1.24%) and hiPSCs (4.17%), respectively in 2D cultured cells (p = 1.948E-
18; α = 0.05; two-tailed Kruskal-Wallis test with Dunn-Bonferroni posthoc test). Interestingly,
posthoc tests show no significant difference between hESC- and hiPSC-derived hepatocytes
maximum. Individual data points represented by  and▲ are mild and extreme outliers, respectively. Statistical
difference level is indicated by ** for p<0.01 according to the results of the Dunn-Bonferroni posthoc tests performed
with the Kruskal-Wallis test (α = 0.05).
https://doi.org/10.1371/journal.pone.0189586.g007
Fig 8. HNF4α expression by hiPSC- or hESC-derived hepatocytes on day 13 of differentiation. (a-b) Immunostaining of the hepatoblast and
hepatocyte marker HNF4α shows its expression by 2D (a) and 3D (b) cultured cells. Nuclei stained with DAPI. The bottom high magnification panel
corresponds to the delineated regions in lower magnification panel above.
https://doi.org/10.1371/journal.pone.0189586.g008
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when cultured in either 2D or 3D (p2DhESCsvs2DhiPSCs = 1, p3DhESCsvs3DhiPSCs = 1)
within cell types when comparing 3D and 2D culture conditions
(p2DhESCsvs3DhESCs = 3.37E-10, p2DhiPSCsvs3DhiPSCs = 3.08E-9). Even when CK-19
expression was evaluated, there were significant differences between the hESC-derived hepato-
cytes (1.63%) and hiPSCs (2.66%) in 3D and the same cells (both 0%) in 2D cultures
(p = 0.003; α = 0.05; two-tailed Kruskal-Wallis test with Dunn-Bonferroni posthoc test, post-
hoc test:; p2DhiPSCsvs3DhiPSCs = 0.002). However, it is probable that there was no real bio-
logical difference between the 4 groups as CK-19 had low expression in all groups.
CK-18 was, therefore, highly expressed within the 3D cultures while expression of CK-19
and CK-7, another ductal plate and cholangiocyte marker [36] was very low. Within the 2D
cultures, only occasional islands of cells expressing CK-18, CK-19 and CK-7 were seen (Figs 9
and 10, and S2 Table).
Interestingly, asialoglycoprotein receptor (ASGPR), which is normally localised at the sinu-
soidal membrane of the hepatocytes, was restricted to a part of the membrane in cells cultured
in 3D, suggesting possible cell polarisation. No ASGPR expression was detected in cells cul-
tured in 2D (Fig 11).
A higher proportion of hiPSC- or hESC-derived hepatocytes are able to
store lipids and synthesize glycogen in 3D than in 2D cultures
We then tested the ability of hESC- or hiPSC-derived cells to store lipids (Oil red O or ORO
staining) and synthesize glycogen (Periodic Acid Schiff or PAS staining), these being primary
hepatocyte functions.
Median expression of ORO was 99.5% for hESC-derived hepatocytes and 99.47% for
hiPSC-derived hepatocytes in 3D at day 13; while only 24.03% (hESCs) and 16.47% (hiPSCs)
of 2D differentiated cells were ORO positive (Fig 12).
The expression of ORO was significantly different between the 4 groups at day 13 of differ-
entiation (p = 8.71E-15; α = 0.05; two-tailed Kruskal-Wallis test with Dunn-Bonferroni post-
hoc test). Posthoc tests show that there was no significant difference between hESC- and
hiPSC-derived hepatocytes when cultured in 2D (p2DhESCsvs2DhiPSCs = 1) nor in 3D
(p3DhESCsvs3DhiPSCs = 1). When comparing the expression of ORO between 3D and 2D culture
conditions, the difference was found to be very significant (p2DhESCsvs3DhESCs = 4.31E-5,
p2DhiPSCsvs3DhiPSCs = 6.17E-11) (Fig 12c and S2 Table).
A higher proportion of hESC- and hiPSC-derived hepatocytes in 3D than in 2D showed a
pink-purple staining due to the presence of polysaccharides indicative of their ability to syn-
thesize glycogen (Fig 13).
Both assays indicate that a higher proportion of cells cultured in 3D are able to acquire
hepatocyte-specific functions.
Discussion
The high proliferation potential of stem cells and their ability to terminally differentiate into
any specialised cell population makes them attractive for applications in regenerative medicine
and disease modelling. However, one of the limitations to the use of stem cells as a source of
hepatocytes is their inability to acquire a fully mature phenotype. Here we tested the utility of
decellularised liver scaffolds for differentiation of both hESCs and hiPSCs.
We focused on scaffolds derived from adult mice livers to provide the adult ECM proteins
in a 3D liver environment in an attempt to better mimic in vivo liver and improve hepatocyte
maturation. We found that in this environment ALB was diffusely present in pluripotent stem
cells after differentiation in 3D cultured cells while only a minimal fraction of the cells were
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Fig 9. CK-18 and CK-19 expression by hiPSC- or hESC-derived hepatocytes in 2D and 3D on day 13 of differentiation. (a-b)
Immunostaining of CK-18, typically expressed by hepatoblasts and hepatocytes and CK-19, expressed by hepatoblasts and cholangiocytes.
Whilst CK-18 staining is seen in both 2D (a) and 3D (b) cultured cells, CK-19 staining is absent in 3D cultures. Nuclei stained with DAPI. (c-d)
Boxplots of percentages of positive cells for CK-18 (c) and CK-19 (d) for each group. The bottom and top of the box are the first and third
quartiles, and the band inside the box is the median. The ends of the whiskers represent the minimum and maximum. Individual data points
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positive when cultured in 2D. In parallel, the expression of the fetal hepatocyte marker AFP
was negligible in 3D cultured cells while it was highly expressed in 2D cultures. These findings
are consistent with the hypothesis that ECM scaffolds can promote cell differentiation. Beside
phenotypic changes, we observed that 3D cultured cells appeared to be more functionally
mature than the same cells maintained in 2D matrigel-coated dishes as shown by an increase
in lipid storage and glycogen synthesis. Moreover, the 3D cultured cells demonstrated some
polarised features such as localised ASGPR expression, which is also characteristic of and cru-
cial to the function of mature hepatocytes.
Different batches of differentiating hESCs produced more consistent results than hiPSCs,
and there were significant differences in staining for ALB and AFP detected between hESC-
and hiPSC-derived hepatocytes mainly when grown in 3D, illustrating the intrinsic differences
between stem cell lines.
Our finding of improved differentiation of stem cells on scaffolds is consistent with previ-
ous studies using different ECM components and 3D culture systems. Individual ECM pro-
teins like laminins, have been shown to improve differentiation of pluripotent stem cells
towards hepatocytes on 2D cultures [23]. Gieseck et al, in 2014 showed that a higher percent-
age of hiPSC-derived hepatocytes grown in 3D clumps are ALB, ORO and PAS positive than
those cultured in 2D, and a lower percentage express AFP, which is consistent with our find-
ings [20]. However, the authors used a longer protocol than the one utilised in this study with
represented by  and▲ are mild and extreme outliers, respectively. Statistical difference level is indicated by ** for p<0.01 according to the
results of the Dunn-Bonferroni posthoc tests performed with the Kruskal-Wallis test (α = 0.05).
https://doi.org/10.1371/journal.pone.0189586.g009
Fig 10. CK-7 expression by hiPSC- or hESC-derived hepatocytes on day 13 of differentiation. (a-b) Immunostaining of CK-7, typically expressed by
ductal plate cells and cholangiocytes (CK7, green) demonstrates expression in 2D cultured (a) but not 3D cultured (b) cells. Nuclei stained with DAPI.
https://doi.org/10.1371/journal.pone.0189586.g010
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the phenotype of the hepatocytes studied at the end of the differentiation showing an improve-
ment in maturation between 35 and 45 days of differentiation.
A number of improvements will be required to further optimise stem cell-derived hepato-
cyte maturation. Firstly, a high percentage of endoderm-like cells produced at the end of prim-
ing definitive endoderm stage is critical for successful hepatocytes differentiation [13],
therefore improving the efficiency and consistency of endoderm production would improve
the quality and reduce the variability between different differentiation batches. Co-culture of
differentiating hepatocytes with endothelial, mesenchymal and other resident liver cells may
further improve differentiation efficiency and hepatocyte maturity [37].
In our experiments, cells seeded onto scaffold did not survive until day 19, the end of the
differentiation protocol. This finding is likely due to insufficient nutrient and oxygen supply
provided to dividing cells in the scaffold in static conditions [38, 39]. Use of a bioreactor to
Fig 11. ASGPR expression by hiPSC- or hESC-derived hepatocytes in 2D or 3D on day 13 of differentiation. (a-b) Immunostaining of hepatocyte
sinusoidal membrane protein ASGPR in 2D (a) and 3D (b) cultured cells. Nuclei stained with DAPI. The higher magnification images of merged channels
in the bottom panel correspond to the delineated lower magnification images in the panel above. Images of 3D cultured cells demonstrate membrane
localisation of ASGPR.
https://doi.org/10.1371/journal.pone.0189586.g011
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Fig 12. Lipid storage by hiPSC- or hESC-derived hepatocytes in 2D or in 3D on day 13 of differentiation. (a-b) Lipids detected by ORO (droplets,
red-orange). Nuclei stained with hematoxylin (purple). Substantially higher percentage of cells are ORO positive in 3D (b) than in 2D (a) on day 13. (c)
Boxplots of percentages of positive cells for ORO for each group. The bottom and top of the box are the first and third quartiles, and the band inside the
box is the median. The ends of the whiskers represent the minimum and maximum. Individual data points represented by  and▲ are mild and extreme
outliers, respectively. Statistical difference level is indicated by ** for p<0.01 according to the results of the Dunn-Bonferroni posthoc tests performed with
the Kruskal-Wallis test (α = 0.05).
https://doi.org/10.1371/journal.pone.0189586.g012
Fig 13. Glycogen synthesis by hiPSC- or hESC-derived hepatocytes on day 13 of differentiation. Periodic Acid Schiff staining (PAS, purple-
magenta) is used to detect intracellular polysaccharides. A higher proportion of PAS positive cells is detected in 3D cultures (b) than in 2D cultures (a) at
day 13 of differentiation. Nuclei were stained with hematoxylin (dark purple).
https://doi.org/10.1371/journal.pone.0189586.g013
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bring a constant flow of oxygenated media would improve the survival of the cells grown
within the scaffold which would allow further differentiation. Furthermore, the bioreactor
grown cells could be subjected to the mechanical forces such as fluid shear stress which have
been shown to promote stem cells endothelial differentiation and revascularisation of the scaf-
fold [40–42].
In this work, we show that a decellularised liver scaffold is an effective tool for stem cell
differentiation.
Production of high numbers of scaffold cultured mature hepatocytes will enable the intro-
duction of drug screening assays not currently employed in the industry but that may signifi-
cantly increase the repertoire of target diseases.
Several recent developments bring the idea of liver regeneration using stem cells closer to
clinical application. The culture of pluripotent stem cells has recently been scaled up allowing
the production of high cell numbers, necessary for application in clinical practice [43, 44].
Decellularised livers from various animal sources can be used as proteins preserved in the
scaffold are unlikely to generate an immune reaction and therefore xenograft model may be
accepted [45–47]. Thus the potential of liver scaffolds may in the future be utilised for terminal
differentiation of stem cells prior to cell transplantation and even whole organ regeneration.
However, further studies are necessary to investigate the safety of hiPSC-derived hepato-
cytes, to improve the efficiency and consistency of differentiation, and to understand the long-
term effect of the interaction between the repopulated cells, the ECM and the recipient.
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